Revelation Biosciences (REVB) Depreciation & Amortization (CF) (2021 - 2026)
Revelation Biosciences' Depreciation & Amortization (CF) came in at $8,313 for Q2 2026, up 15.1% from $7,220 a year earlier and up 15.4% from the prior quarter.
Revelation Biosciences (REVB) Depreciation & Amortization (CF) (2021 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Revelation Biosciences reported Depreciation & Amortization (CF) of $28,133, down 2.6% year-over-year; for FY2025, it was $27,058, down 3.1% from FY2024.
- Depreciation & Amortization (CF) carries a four-year compound annual growth rate of 12.7% (FY2021 to FY2025).
- Going back by year, Depreciation & Amortization (CF) was $27,923 in FY2024 (+11.5%), $25,049 in FY2023 (unchanged), $25,048 in FY2022 (+49.3%) and $16,782 in FY2021.
- The Q2 2026 figure represents the highest quarterly Depreciation & Amortization (CF) in data going back to Q1 2021.
- Year-over-year, Depreciation & Amortization (CF) increased in four of the last eight quarters, with growth averaging 4.4%.
- The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in Q2 2022 (growth of 875.4%), and the weakest in Q4 2025 (a decline of 19.0%).
- Business Quant data shows REVB's Depreciation & Amortization (CF) at $7,203 (Q1 2026), $5,852 (Q4 2025) and $6,765 (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.96 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 194.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 599.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.93 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.11 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 98.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 1.62 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 56.50 Mn |
| 10 | Revelation Biosciences | 3.20 Mn | -45.82 Mn | - | 8,313.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8,313.00 |
| Mar 31, 2026 | 7,203.00 |
| Dec 31, 2025 | 5,852.00 |
| Sep 30, 2025 | 6,765.00 |
| Jun 30, 2025 | 7,220.00 |
| Mar 31, 2025 | 7,221.00 |
| Dec 31, 2024 | 7,221.00 |
| Sep 30, 2024 | 7,220.00 |
| Jun 30, 2024 | 7,220.00 |
| Mar 31, 2024 | 6,262.00 |
| Dec 31, 2023 | 6,262.00 |
| Sep 30, 2023 | 6,262.00 |
| Jun 30, 2023 | 6,262.00 |
| Mar 31, 2023 | 6,263.00 |
| Dec 31, 2022 | 6,262.00 |
| Sep 30, 2022 | 6,262.00 |
| Jun 30, 2022 | 6,262.00 |
| Mar 31, 2022 | 6,262.00 |
| Dec 31, 2021 | 6,262.00 |
| Sep 30, 2021 | 6,071.00 |
Revelation Biosciences Depreciation & Amortization (CF) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=REVB&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-amortization-cf", "ticker": "REVB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=REVB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();